Bio-Rad Laboratories (BIO) Free Cash Flow (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Free Cash Flow data on file, last reported at $78.1 million in Q1 2026.

• On a quarterly basis, Free Cash Flow fell 18.22% year-over-year to $78.1 million in Q1 2026; TTM through Mar 2026 was $357.2 million, a 0.48% change from a year earlier, with the FY2025 full-year figure at $374.6 million, up 29.35% from the prior year.
• Free Cash Flow for Q1 2026 stood at $78.1 million, down from $119.1 million in the prior quarter.
• Over the last five years, Free Cash Flow for BIO reached as high as $123.4 million in Q3 2024 and fell as low as -$16.6 million in Q3 2022.
• Historically, Free Cash Flow has averaged $61.3 million across 5 years, with a median of $62.4 million in 2023.
• Across the five-year window, Free Cash Flow plunged 108.47% in 2022 and surged 423.33% in 2023, its largest moves.
• Year by year, Free Cash Flow stood at $44.8 million in 2022, then retreated by 13.52% to $38.7 million in 2023, then jumped by 109.87% to $81.3 million in 2024, then soared by 46.49% to $119.1 million in 2025, then sank by 34.42% to $78.1 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $78.1 million in Q1 2026, $119.1 million in Q4 2025, and $89.2 million in Q3 2025.